Litigation Finance vs. After-the-Event Insurance

Litigation finance suits a claimant or firm that needs actual capital — to cover costs, cash flow, or firm operations — while a case proceeds, not just protection against the other side's costs if the case is lost, and applies regardless of which country's cost-shifting rules govern the claim. The need for capital exists whether or not the jurisdiction imposes any cost-shifting risk on an unsuccessful claimant.

After-the-event insurance suits a claimant, particularly in jurisdictions with loser-pays cost-shifting rules, who needs protection against being ordered to pay the opposing party's legal costs if the case is unsuccessful, rather than upfront capital, and is largely irrelevant in jurisdictions that do not shift costs to the losing party. A claimant who already has sufficient capital to fund the litigation itself may still need ATE cover purely for the adverse-costs protection.

The funder advances capital against the expected value of the claim, repaid as a multiple of investment or a share of recovery if the case succeeds, with the funder receiving nothing and the claimant owing nothing if the case fails, functioning entirely independently of any cost-shifting exposure the claimant might separately face. The capital can be drawn down over the life of the case rather than delivered as a single lump sum, depending on the facility's structure.

The insurer issues a policy that pays the opposing party's awarded costs if the claim is unsuccessful, in exchange for a premium — often deferred and contingent, payable only if the case succeeds — with no capital advanced to the claimant for case costs or living expenses, since the policy addresses a liability, not a funding need. Some policies are arranged before litigation is filed, while others are obtained once a case is already underway, depending on when the need for cover is identified.

Litigation finance is priced as a return on the capital actually deployed, scaled to the amount advanced and the risk of the underlying claim, since real cash changes hands during the case and the funder is exposed to the full range of outcomes affecting that capital. Pricing also reflects the expected duration of the litigation, since capital tied up longer requires a higher return to compensate the funder.

ATE insurance is priced as a premium against the potential adverse-costs exposure being insured, typically smaller in absolute terms than a capital advance because it covers a defined cost-shifting liability rather than funding the case itself, and scales with the litigation's procedural stage rather than the claim's total value. Premiums can also vary by the strength of the underlying claim, since a stronger claim presents a lower probability the policy will ever be triggered.

The funder bears the risk of losing its entire advance if the case fails, since the arrangement is non-recourse — there is no capital repayment obligation if the claim is unsuccessful, leaving the claimant's exposure limited to whatever adverse-costs risk exists separately. This risk allocation is unrelated to, and unaffected by, whatever adverse-costs exposure the claimant separately carries in a loser-pays jurisdiction.

The insurer bears the risk of paying the opposing party's costs if the case fails and the policy is triggered, but does not bear any exposure related to capital the claimant might have needed for the case itself, meaning the two products address entirely separate risks even when used on the same matter. Insurers price this exposure independently of any capital arrangement the claimant has separately made for the litigation itself.

Litigation finance wins whenever the claimant or firm needs actual cash during the litigation — for costs, experts, or operations — regardless of whether adverse-costs exposure is also a concern, since the two needs can exist independently of each other.

ATE insurance wins in loser-pays jurisdictions where the primary risk to manage is exposure to the opponent's costs, and the claimant does not need capital advanced against the case, or already has sufficient resources to fund the litigation itself. It is frequently paired with litigation finance specifically because the two products, taken together, cover both the funding need and the adverse-costs exposure comprehensively.